Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Express Scripts
AstraZeneca
Baxter
Johnson and Johnson

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

AMPICILLIN AND SULBACTAM Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Ampicillin And Sulbactam patents expire, and when can generic versions of Ampicillin And Sulbactam launch?

Ampicillin And Sulbactam is a drug marketed by Acs Dobfar, Antibiotice, Astral, Aurobindo Pharma, Hanford Gc, Hospira Inc, Istituto Bio Ita Spa, Mustafa Nevzat Ilac, Mylan Labs Ltd, Sandoz, and West-ward Pharms Int. and is included in twenty-three NDAs.

The generic ingredient in AMPICILLIN AND SULBACTAM is ampicillin sodium; sulbactam sodium. There are seventy drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the ampicillin sodium; sulbactam sodium profile page.

Summary for AMPICILLIN AND SULBACTAM
Drug patent expirations by year for AMPICILLIN AND SULBACTAM
Recent Clinical Trials for AMPICILLIN AND SULBACTAM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mercy Health OhioPhase 4
DongGuk UniversityN/A
Medical University of ViennaPhase 3

See all AMPICILLIN AND SULBACTAM clinical trials

Pharmacology for AMPICILLIN AND SULBACTAM

US Patents and Regulatory Information for AMPICILLIN AND SULBACTAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz AMPICILLIN AND SULBACTAM ampicillin sodium; sulbactam sodium INJECTABLE;INJECTION 065241-002 Jul 25, 2006 AP RX No No   Start Trial   Start Trial   Start Trial
Mylan Labs Ltd AMPICILLIN AND SULBACTAM ampicillin sodium; sulbactam sodium INJECTABLE;INJECTION 201024-002 Apr 7, 2014 AP RX No No   Start Trial   Start Trial   Start Trial
Sandoz AMPICILLIN AND SULBACTAM ampicillin sodium; sulbactam sodium INJECTABLE;INJECTION 065310-002 Jul 25, 2006 AP RX No No   Start Trial   Start Trial   Start Trial
Mylan Labs Ltd AMPICILLIN AND SULBACTAM ampicillin sodium; sulbactam sodium INJECTABLE;INJECTION 202197-001 Apr 7, 2014 AP RX No No   Start Trial   Start Trial   Start Trial
Acs Dobfar AMPICILLIN AND SULBACTAM ampicillin sodium; sulbactam sodium INJECTABLE;INJECTION 065406-001 Dec 22, 2009 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Boehringer Ingelheim
McKinsey
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.